People with diabetes generally need two core kidney screening tests: a urine test that measures how much albumin is spilling into the urine (expressed as a ratio called UACR), and a blood test that measures creatinine and is used to calculate estimated glomerular filtration rate (eGFR). ADA guidance generally recommends at least annual assessment for people with type 2 diabetes and for people with type 1 diabetes after five years. Together, these two measurements give a care team a clearer picture than either one alone, because each reflects a different aspect of how the kidneys are functioning.
Key takeaways
- The two core diabetes kidney screening tests are the urine albumin-to-creatinine ratio (UACR) and serum creatinine used to calculate eGFR — both are needed because they each capture something the other cannot.
- ADA guidance generally recommends at least annual kidney assessment for people with type 2 diabetes and for people with type 1 after five years of duration; timing changes with existing kidney disease, symptoms, pregnancy, other health conditions, and clinician judgment.
- An elevated UACR on a single sample often needs repeat confirmation because temporary factors — such as illness, physical exertion, or other variables — can affect the result; your care team interprets trends over time, not single numbers in isolation.
- These tests are screening tools that help a care team look for changes over time — they do not diagnose kidney disease on their own, and results should always be discussed with your clinician rather than self-interpreted.
Short Answer: What Kidney Tests Are Needed for Diabetes?
ADA guidance generally describes two core kidney screening tests for people with diabetes: a urine albumin-to-creatinine ratio (UACR), which measures how much of the protein albumin is leaking into the urine, and a serum creatinine measurement used to calculate eGFR, which estimates how well the kidneys are filtering the blood. Both are needed together, and timing depends on diabetes type, duration, prior results, and clinician judgment.
Why Do the Kidneys Deserve Their Own Screening Conversation?
The kidneys are two fist-sized organs that filter roughly 200 liters of blood every day, remove waste, regulate fluid balance, and control blood pressure through several chemical pathways. For people with diabetes, the same mechanism that drives complications elsewhere in the body — persistently elevated blood glucose stressing small blood vessels — acts directly on the delicate filtering structures inside each kidney, called glomeruli.
How diabetes affects the body's systems over time, including the small vessels that supply every organ, is covered in depth in the body hub. Kidney involvement is part of that wider picture, not an isolated concern.
When those small vessels are stressed, the kidneys can begin to lose their ability to filter selectively. One of the earliest measurable signs is that a protein called albumin — which the kidneys normally keep inside the blood — starts to appear in the urine. Later, the kidneys' overall filtering rate may slow. Both of those changes are detectable with the two standard tests long before symptoms appear, which is why screening exists and why clinicians repeat it on a schedule rather than waiting until something feels wrong.
What Is Albumin — and Why Does It Appear in Urine?
Albumin is the most abundant protein in your blood. Healthy kidneys act as highly selective filters: they let waste products and water through, but they hold back large proteins like albumin. When the filtering membranes are damaged or stressed, small amounts of albumin begin to slip through.
The medical term for albumin in the urine is albuminuria (sometimes called proteinuria in broader contexts). The key word in the test name — urine albumin-to-creatinine ratio (UACR) — reflects how the result is reported. Rather than relying on a timed 24-hour urine collection (which is cumbersome), most modern clinical practice uses a single morning spot urine sample and measures albumin alongside creatinine to create a ratio. That ratio helps account for how concentrated or dilute the urine happened to be at collection time, making the result more consistent.
The UACR is reported in milligrams of albumin per gram of creatinine (mg/g). Your clinician knows what ranges their laboratory uses and what the result means in the context of your full health picture — interpreting a number by itself, without that context, is not recommended.
What Is Creatinine — and What Is eGFR?
Creatinine is a natural waste product produced at a fairly steady rate by muscle metabolism. Healthy kidneys filter it out of the blood and excrete it in urine continuously. When kidneys are not filtering efficiently, creatinine builds up in the blood, and a blood test can detect that buildup.
eGFR stands for estimated glomerular filtration rate — an estimate of how many milliliters of blood the kidneys are filtering per minute, adjusted for body size. It is calculated from serum (blood) creatinine along with variables such as age and sex. A higher number generally reflects better filtering capacity; a lower number suggests the kidneys may not be filtering as efficiently.
The word "estimated" is important. eGFR is a calculation, not a direct measurement. Factors like muscle mass, certain medicines, recent dietary protein intake, and laboratory methods can all influence the creatinine reading that feeds the formula, which is why clinicians interpret eGFR trends over multiple visits alongside other clinical information rather than treating any single result as definitive.
It is also worth noting that a normal creatinine value alone does not rule out kidney changes — which is exactly why both UACR and eGFR together are the standard approach, rather than relying on one alone.
Why Both Tests Are Needed: A Comparison
UACR and eGFR each reveal something the other cannot. In early kidney stress related to diabetes, albumin often begins appearing in urine while the overall filtration rate is still within a normal range. In other situations, filtration rate may change without large albumin levels. Using only one test can miss changes that the other would detect.
| Test | Specimen Type | What It Measures | What It Reveals | Key Limitation |
|---|---|---|---|---|
| UACR | Urine (spot sample) | Albumin relative to creatinine in urine | How much albumin is leaking through kidney filters | Temporary factors (illness, heavy exercise, fever) can transiently raise albumin; a single elevated result often needs repeat confirmation |
| eGFR | Blood (serum creatinine) | Estimated filtering rate of the kidneys | Overall kidney filtering efficiency | Calculated estimate; influenced by muscle mass, diet, medicines, and lab method; trends matter more than one number |
Together, UACR and eGFR give a care team a two-dimensional picture: the integrity of the filtering membrane (albumin leakage) and the overall rate of filtration (eGFR). That is why professional guidance describes using both, not choosing between them.
How Often Does ADA Guidance Generally Recommend Kidney Screening?
ADA guidance generally recommends at least annual assessment of kidney function — using both UACR and serum creatinine to calculate eGFR — for all people with type 2 diabetes and for people with type 1 diabetes after five years of duration.
That said, "at least annual" is a baseline description, not a universal rigid schedule. Timing and frequency change in a variety of circumstances, including:
- Established kidney disease. When eGFR or UACR results already show kidney changes, clinicians often monitor more frequently — the appropriate interval depends on what stage of change is present and on the care team's judgment. Professional guidance generally describes more frequent monitoring in established chronic kidney disease, but staging and management decisions belong with the clinician, not with the patient interpreting their own numbers.
- Type 1 diabetes duration. The five-year mark is a general threshold used in professional guidance; what that means for a specific person depends on their history and how their diabetes has been managed.
- Pregnancy. Diabetes in pregnancy requires closer attention from the obstetric and diabetes care teams, and kidney assessment timing is part of that individualized prenatal plan.
- Other health conditions. High blood pressure, heart disease, urinary tract infections, and other factors all inform how a care team monitors kidney health.
- Medications. Some medicines used in diabetes management have kidney-related considerations, and a care team tracks kidney function partly to guide those decisions safely.
- Prior results. A consistently stable pattern over many years may influence how a clinician thinks about interval; an unexpectedly changed result will prompt earlier follow-up.
- Symptoms. Swelling, changes in urine pattern, fatigue, and other symptoms can prompt assessment outside any fixed schedule.
The bottom line is that no single article can tell you how often you personally should be tested. ADA guidance describes at least annual assessment as a general framework, and your clinician applies that to your individual situation. If you are unsure how often your kidneys are being checked or why, that is a good question to bring to your next appointment — the diabetes appointment preparation checklist can help you organize that conversation in advance.
What Does the Urine Specimen Collection Process Involve?
For the UACR, you will provide a urine sample. In most clinical settings today, a spot urine sample — typically collected first thing in the morning before eating or drinking much — is used. You will be given a clean specimen container. The process is non-invasive and typically takes only a few minutes.
A few general points to be aware of:
- Temporary factors can affect how much albumin appears in a single urine sample. These include recent vigorous exercise, fever, a urinary tract infection or other illness, extreme dehydration or overhydration, and possibly other variables. This is not something to try to manage yourself before a test — it is simply why clinicians often want to confirm an elevated result with one or more repeat samples before drawing conclusions. If your care team mentions confirming a result, that is normal clinical practice, not cause for alarm.
- The urine sample is sent to a laboratory. Results are typically reported back through your care team or patient portal.
- If your care team asks you to collect urine at a specific time of day, following those instructions improves accuracy.
The blood draw for serum creatinine follows the same process as any routine blood test. A small sample of blood is drawn from a vein, usually in the arm, and analyzed by a laboratory.
Why a Single Elevated UACR Often Needs Repeat Confirmation
This point deserves its own section because it comes up often and can cause confusion. If you receive a lab result showing elevated albumin and your clinician says they want to repeat the test, it does not necessarily mean your kidneys are in serious trouble. It means your clinician is following standard clinical practice.
Because so many temporary factors — illness, strenuous activity, a urinary tract infection, or timing within the day — can transiently push albumin levels up, clinical guidance generally calls for confirming an elevated UACR with a repeat sample, often at a different time point, before using it to make decisions. The pattern across two or three samples over a few months is more meaningful than any single value.
Conversely, a normal UACR on a single sample in someone with other concerning clinical signs will still prompt a thorough clinical evaluation. Your clinician holds the full picture; the test is one input, not the whole story.
What the Tests Do Not Tell You (and Why That Matters)
Understanding what kidney tests cannot do is just as important as understanding what they can:
- They do not diagnose kidney disease by themselves. Kidney disease is a clinical diagnosis that considers multiple factors: your symptom history, physical exam, medication list, blood pressure trends, other laboratory findings, and how results change over time.
- They do not tell you what stage your kidney health is at. Staging chronic kidney disease is a clinical process that belongs with your care team. Knowing a number and looking up stages online does not give you the context your clinician has.
- A single normal result does not mean permanent reassurance. Screening is designed to be repeated because kidney health can change over time, especially when diabetes is ongoing.
- Results mean different things in different people. The same UACR number in a 35-year-old newly diagnosed with type 2 diabetes means something different than it does in a 70-year-old with 25 years of type 1, high blood pressure, and a recent urinary tract infection.
- Normal creatinine alone does not rule out kidney changes. This is a common misunderstanding. The serum creatinine must be used alongside age and sex to calculate eGFR, and eGFR should be considered alongside UACR — not independently.
Questions to Bring to Your Care Team About Kidney Screening
The goal of knowing about these tests is to help you have a more informed conversation with your clinician — not to interpret your own results or adjust your schedule on your own. Here are questions that many people find useful to ask:
- Are my kidney tests up to date? Have I had both a UACR and a creatinine/eGFR in the last year, or does anything need to be scheduled?
- What do my results mean in the context of my history? Rather than asking what a number means in isolation, ask what the trend looks like over my last few visits.
- How often should I expect my kidneys to be checked, given my specific situation? Annual is the general guidance, but your clinician may have a different interval in mind for you.
- Is there anything about my current medications, diet, or other health conditions that affects how you interpret my kidney results?
- If my UACR came back elevated, what happens next? Knowing the process — whether a repeat test is planned, when results should be expected — reduces anxiety about what the numbers mean.
- Are there signs or symptoms I should contact you about before my next scheduled visit?
How Kidney Screening Fits Into the Wider Diabetes Screening Picture
Kidney tests are one part of a broader set of conversations that make up comprehensive diabetes care. ADA guidance also describes regular assessment for blood pressure, A1C, blood lipids, eye health, foot health, dental health, and vaccinations — among others. As explored in the article on what diabetes tests are generally needed each year, there is no single rigid universal annual checklist; the right set of screenings, and their timing, depends on individual circumstances, which is why clinician-led care planning matters more than any checklist alone.
Eye screening and kidney screening are often discussed together because both address how sustained high blood sugar affects small blood vessels — the eyes and kidneys rely on some of the most delicate capillary networks in the body. The article on how often people with diabetes generally need an eye exam covers that parallel in depth.
Foot and nerve screening, addressed in how often a diabetic foot exam is generally recommended, rounds out the picture of small-vessel and nerve-related monitoring. All three — kidney, eye, and foot — share the logic of looking for changes before symptoms appear.
Talking to Your Care Team: What Good Screening Communication Looks Like
People who understand what they are being screened for tend to ask better questions and follow through more consistently on recommended testing. A few practical principles:
- Know which tests are on your care team's radar. If you are not sure whether your UACR and eGFR have been checked recently, ask directly. Your portal or records often show this, or your care team can review it with you.
- Bring your questions written down. Short appointments pass quickly. Writing down even two questions before you arrive — "Have my kidney tests been done this year?" and "What should I know about my last results?" — makes a real difference. The diabetes appointment preparation checklist is designed to help with exactly this kind of preparation.
- Ask about trends, not just single numbers. A one-time UACR or eGFR value means less than a pattern over several visits. Ask your care team how your pattern looks.
- Understand why a repeat test was ordered. If your clinician wants to repeat the UACR, ask whether that is routine confirmation (common) or whether they noticed something worth monitoring more closely.
- Connect screening to your daily life appropriately. Managing blood sugar and blood pressure over time is part of why screening conversations happen — not because those actions guarantee any specific result, but because your care team considers your ongoing management patterns as context. Diabetes self-management education and support programs (DSMES) exist partly to help people build those daily management skills in a structured, credentialed setting.
Frequently Asked Questions
What is UACR and why is it used for diabetes kidney screening?
UACR stands for urine albumin-to-creatinine ratio. It measures how much of the protein albumin is appearing in the urine relative to creatinine, which serves as a marker for how concentrated the urine is. Healthy kidneys normally hold albumin in the blood; when the filtering structures are stressed, albumin begins to leak into the urine. UACR uses a spot urine sample rather than a timed 24-hour collection, making it practical for routine screening. ADA guidance describes it as one of the two core kidney screening measures for people with diabetes.
What does eGFR measure and why does it matter for diabetes?
eGFR stands for estimated glomerular filtration rate. It is calculated from serum creatinine along with age and sex, and it estimates how efficiently the kidneys are filtering the blood. Because creatinine is a waste product that healthy kidneys continuously remove, a buildup in the blood suggests reduced filtering capacity. eGFR gives a care team a sense of overall kidney filtering efficiency, which is a different dimension of kidney health than what UACR captures. Together, both tests provide a more complete picture than either alone.
Why do I need both UACR and eGFR — can I just have one?
UACR and eGFR each detect different aspects of how the kidneys are working. In early kidney stress related to diabetes, albumin often begins appearing in the urine before the overall filtration rate drops. In other people, filtration rate may change without a large rise in urine albumin. Relying on only one test can miss changes that the other would detect. ADA guidance describes using both as the standard approach for people with diabetes rather than choosing between them.
What happens if my UACR comes back elevated?
An elevated UACR on a single sample does not automatically mean you have kidney disease. Temporary factors such as recent illness, vigorous exercise, fever, or a urinary tract infection can transiently raise albumin levels in the urine. Because of this, clinical practice generally calls for confirming an elevated result with one or more repeat samples before using it to make clinical decisions. Your care team will interpret the result in the context of your full health picture and let you know whether a repeat test is the next step or whether further evaluation is needed.
How often should people with diabetes have kidney tests done?
ADA guidance generally recommends at least annual kidney assessment using both UACR and serum creatinine for eGFR for people with type 2 diabetes and for people with type 1 diabetes after five years of duration. That annual baseline changes based on individual circumstances, including existing kidney disease, blood pressure, other health conditions, medications, prior results, pregnancy, and symptoms. The appropriate schedule for any individual is a decision made with their care team, not something a general article can prescribe.
Can a normal creatinine blood test alone confirm my kidneys are fine?
No. A normal serum creatinine alone does not rule out kidney changes. Creatinine must be used alongside age and sex to calculate eGFR, and eGFR reflects overall filtering efficiency only — it does not capture whether albumin is leaking into the urine, which is what UACR measures. Both tests together give a more complete picture. Additionally, results mean different things in different people depending on muscle mass, medications, other health conditions, and individual history, which is why clinical interpretation by a care team is essential.
References
- American Diabetes Association — 2026 Standards of Care: Chronic Kidney Disease and Risk Management
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Diabetic Kidney Disease
- National Kidney Foundation — Estimated GFR
- Centers for Disease Control and Prevention — Diabetes and Chronic Kidney Disease
- National Kidney Foundation — Urine Albumin-to-Creatinine Ratio (UACR)
Next Steps
If this article raises questions about how your kidneys are being monitored, the most useful step is to bring those questions to your care team. Ask whether both UACR and serum creatinine have been checked recently, what your trend looks like over time, and how often your care team plans to screen based on your specific history.
Before your next visit, consider writing down your two or three most important questions about kidney health. The diabetes appointment preparation checklist is a practical starting point for organizing that kind of visit-ready list.
For people who want structured, ongoing support for building daily diabetes management habits, Done With Diabetes™ is an education and support program designed to work alongside — never in place of — your medical care team. It focuses on practical skills and daily routines, not on interpreting tests or adjusting medications. You can learn about the natural protocol for type 2 diabetes at the program site.